The TCRC Experts List: True Experts in the Field of Testicular Cancer
Testicular cancer is relatively rare. Even excellent urologists, oncologists, pathologists, radiologists and primary-care physicians may see relatively few cases, and the uncommon or complicated cases may require experience that is difficult to acquire without treating this disease regularly.
Why does this matter? Testicular cancer is highly curable, but getting the diagnosis and treatment exactly right can matter enormously. Pathology review can change a diagnosis or treatment plan, complex surgery such as RPLND is best performed by surgeons who do it regularly, and relapsed or poor-prognosis germ cell tumors are situations in which experience can be particularly important. The medical literature has repeatedly supported the value of specialized expertise and experienced centers. See, for example, the TCRC-listed article Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.
For that reason, the TCRC has long encouraged patients to obtain the right diagnosis and treatment from the right source. Sometimes that means a second opinion without changing doctors. Sometimes it means having pathology reviewed by an expert, discussing a difficult case with someone who sees many germ cell tumors, or traveling for a particularly specialized operation or treatment.
This is not a list of every good doctor who can treat testicular cancer, and it is not meant to imply that a doctor who is not listed here is unqualified. It is a deliberately selective list of physicians whom the TCRC believes have substantial experience, expertise, research involvement or a long-standing role in the testicular/germ cell tumor field. The list is also not a ranking.
Everyone on this page is here because of meaningful expertise. A ★ identifies physicians whose work has been especially centered on testicular or germ cell tumors, or who have long been recognized as leaders in the field. The star is not a score, and some experts whose practice has broadened or changed may not have one.
Some important experts are no longer in full-time clinical practice but remain active in research, teaching, consultation or collaborative work. Where that is known, it is noted so that the list does not accidentally imply that an appointment can be made with someone who is no longer seeing patients.
If your cancer has recurred after initial treatment, if the initial treatment has not worked, if you are facing complex surgery, or if there is significant uncertainty about the diagnosis or treatment plan, we strongly encourage consultation with an experienced germ cell tumor expert.
Because doctors move and institutional websites change frequently, the doctor's name is linked whenever possible to a current institutional, hospital, practice or professional page that can help you locate the doctor and obtain current contact information. The TCRC intentionally does not publish private email addresses.
If you find a broken link, a doctor who has moved or retired, or someone whose status should be updated, please contact us.
United States
Indiana
Medical Oncology
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis
Medical Oncology
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis
Medical Oncology
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis
Medical Oncology
Indiana University School of Medicine / IU Simon Comprehensive Cancer Center
Indianapolis
Historical testicular cancer expert; current clinical TC activity is limited/unclear
Urologic Oncology
Indiana University School of Medicine / IU Health
Indianapolis
Urologic Oncology
Indiana University School of Medicine / IU Health
Indianapolis
Urology / Urologic Oncology
Indiana University School of Medicine
Indianapolis
Professor Emeritus; retired from regular clinical practice
Urologic Oncology
Indiana University School of Medicine
Indianapolis
Professor Emeritus; retired from clinical practice, remains involved in research and education
Cardiothoracic / Thoracic Surgery
Community Health Network / Community MD Anderson Cancer Center
Indianapolis
Special expertise: Mediastinal germ cell tumor surgery
Pathology Second Opinions
IU Health Pathology Laboratory / Indiana University School of Medicine
Indianapolis
Indiana University is internationally recognized for expertise in testicular cancer pathology and provides second-opinion review of pathology from other hospitals. Patients generally do not need to obtain or ship their own slides. Ask your oncologist, urologist, or the pathology department at the hospital where your surgery was performed to arrange a testicular cancer pathology consultation with Indiana University Health. The hospital pathology department will normally send the appropriate slides or tissue and your original pathology report directly to IU. If you or your doctor's office need help arranging a consultation, contact IU Health Pathology Client Services at 800-433-0740 or 317-491-6000.
Medical Oncology / Hematology
Franciscan Health Oncology & Hematology Specialists
Lafayette
New York
Medical Oncology
Memorial Sloan Kettering Cancer Center
New York
Medical Oncology
Memorial Sloan Kettering Cancer Center
New York
Medical Oncology
Memorial Sloan Kettering Cancer Center
New York
Medical Oncology
Memorial Sloan Kettering Cancer Center
New York
Historical germ cell tumor expert; no longer actively treats testicular cancer
Urologic Oncology
Memorial Sloan Kettering Cancer Center
New York
Urologic Oncology
Memorial Sloan Kettering Cancer Center
New York
Urologic Oncology
Memorial Sloan Kettering Cancer Center
New York
Massachusetts
Urologic Oncology
Massachusetts General Hospital
Boston
Ohio
Medical Oncology
Case Comprehensive Cancer Center / Cleveland
Cleveland
Current institutional affiliation is being rechecked.
Washington
Urologic Oncology
University of Washington / Fred Hutch
Seattle
Medical Oncology
Fred Hutch / University of Washington
Seattle
Oregon
Medical Oncology / Germ Cell Tumor Research
Testicular Cancer Commons
Beaverton / Portland area
Special expertise: Germ cell tumor research, clinical trials, collaborative expert consultation
Not currently in clinical practice; active in germ cell tumor research and collaborative programs
Medical Oncology / Hematology
Providence Cancer Institute
Portland
Medical Oncology
OHSU Knight Cancer Institute
Portland
Medical Oncology
OHSU Knight Cancer Institute
Portland
Pennsylvania
Medical Oncology
University of Pennsylvania / Abramson Cancer Center
Philadelphia
Special expertise: Survivorship
Emeritus; clinical activity unclear
Urologic Oncology
Penn Medicine
Philadelphia
New Jersey
Urologic Oncology
Rutgers Cancer Institute / Rutgers Health
New Brunswick
Illinois
Urology / Urologic Oncology
Rush University Medical Center
Chicago
Colorado
Pediatric Urology / Urologic Oncology
Children's Hospital Colorado / University of Colorado
Aurora
Urologic Oncology
University of Colorado Anschutz
Aurora
California
Urologic Oncology
USC / Keck Medicine
Los Angeles
Medical Oncology
USC / Keck Medicine
Los Angeles
Urologic Oncology
UCLA Health
Los Angeles
Urologic Oncology
UC San Diego
San Diego
Urologic Oncology
UCSF Health
San Francisco
Urologic Oncology
Stanford Medicine
Stanford
Medical Oncology
Stanford Medicine
Stanford
Utah
Urologic Oncology
University of Utah / Huntsman Cancer Institute
Salt Lake City
South Carolina
Urology / Urologic Oncology
Self Regional / regional urology practice
Greenwood/Greenville
Oklahoma
Urologic Oncology
University of Oklahoma / OU Health
Oklahoma City
Texas
Urologic Oncology
Baylor College of Medicine
Houston
Urology / Urologic Oncology
Baylor College of Medicine / VA (legacy/current uncertain)
Houston
Maryland
Urologic Oncology
Johns Hopkins Medicine / Brady Urological Institute
Baltimore
Alabama
Urologic Oncology
UAB Medicine / O'Neal Comprehensive Cancer Center
Birmingham
And Around the World
Canada
Urologic Oncology
Princess Margaret Cancer Centre / University of Toronto
Toronto, Ontario
Radiation Oncology
Princess Margaret Cancer Centre / University of Toronto
Toronto, Ontario
Radiation Oncology
Princess Margaret Cancer Centre / University of Toronto
Toronto, Ontario
Urologic Oncology
University of Toronto / Princess Margaret (historical/current academic)
Toronto, Ontario
Professor Emeritus; no longer performing surgery
Medical Oncology
BC Cancer / University of British Columbia
Vancouver, British Columbia
Medical Oncology
BC Cancer / University of British Columbia
Vancouver, British Columbia
Special expertise: Germ cell tumors and circulating miR-371 biomarkers
Medical Oncology
Dalhousie University / Nova Scotia Cancer Centre
Halifax, Nova Scotia
France
Medical Oncology
Centre Oscar Lambret; ongoing academic/clinical GU oncology role
Lille, Hauts-de-France
Medical Oncology
AP-HP (Saint-Louis / Bichat / Beaujon network)
Paris, Île-de-France
United Kingdom
Urologic Oncology
Royal Marsden
London, England
Medical Oncology
Barts Cancer Centre / Barts Health
London, England
Clinical Oncology / Radiation Oncology
Institute of Cancer Research / Royal Marsden
London/Sutton, England
Urologic Oncology
The Christie NHS Foundation Trust
Manchester, England
Urology
University Hospital Southampton / Wessex
Southampton, England
Medical Oncology
University Hospital Southampton
Southampton, England
Ireland
Medical Oncology
St Vincent's University Hospital / St Vincent's Private Hospital
Dublin, Dublin
Norway
Medical Oncology
Akershus University Hospital / University of Oslo
Lørenskog/Oslo, Oslo/Viken
Oncology / Survivorship
Oslo University Hospital / University of Oslo
Oslo, Oslo
Professor Emerita; retired from clinical service and remains active in survivorship research
Medical Oncology
University Hospital of North Norway / UiT
Tromsø, Troms
Medical Oncology
St. Olavs Hospital / NTNU
Trondheim, Trøndelag
Netherlands
Medical Oncology
UMCG
Groningen, Groningen
Medical Oncology
Erasmus MC (research affiliation/current profile)
Rotterdam, South Holland
Retired from patient care; remains active in research, teaching and advisory work
Germany
Urologic Oncology
University Hospital Düsseldorf
Düsseldorf, North Rhine-Westphalia
Urology / Uro-Oncology
University Hospital Cologne
Cologne, North Rhine-Westphalia
Special expertise: Advanced and metastatic testicular germ cell tumors
Urologic Oncology
University Hospital Cologne
Cologne, North Rhine-Westphalia
Medical Oncology / Hematology
University Medical Center Hamburg-Eppendorf (UKE)
Hamburg, Hamburg
Hematology / Medical Oncology
Franziskus Hospital Bielefeld
Bielefeld, North Rhine-Westphalia
Medical Oncology / Hematology
Rotkreuzklinikum München
Munich, Bavaria
Medical Oncology / Uro-Oncology
Charité – Universitätsmedizin Berlin
Berlin, Berlin
Austria
Sweden
Medical Oncology / Oncology Research
Karolinska Institutet
Stockholm, Stockholm
Switzerland
Medical Oncology
Inselspital Bern
Bern, Bern
Medical Oncology / Hematology
Kantonsspital Graubünden
Chur, Graubünden
Medical Oncology
Oncology Institute of Southern Switzerland / Università della Svizzera italiana
Lugano, Ticino
Medical Oncology / Uro-Oncology
University Hospital Zurich
Zürich, Zürich
Denmark
Medical Oncology
Rigshospitalet
Copenhagen, Capital Region
Italy
Medical Oncology
IRST IRCCS
Meldola, Emilia-Romagna
Medical Oncology
IRCCS San Raffaele Hospital
Milan, Lombardy
Urologic Oncology
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy
Israel
Urology / Urologic Oncology
Rabin Medical Center
Petah Tikva, Central District
Slovakia
Medical Oncology
National Cancer Institute / Comenius University
Bratislava, Bratislava
Spain
Medical Oncology
Institut Català d'Oncologia / IOB (legacy/current)
Barcelona, Catalonia
Australia
Medical Oncology
Peter MacCallum Cancer Centre
Melbourne, Victoria
Medical Oncology
Peter MacCallum Cancer Centre
Melbourne, Victoria
Medical Oncology
Chris O'Brien Lifehouse / Royal Prince Alfred Hospital / University of Sydney
Sydney, New South Wales
Medical Oncology
Epworth Eastern / Eastern Oncology
Melbourne, Victoria
Urology / Urologic Oncology
Mater Hospital / St Vincent's Private Hospital
Sydney, New South Wales
If you know of someone else who you believe belongs on this list, or have a correction to an existing entry,
please tell Doug.
Click on this to go back to the TCRC main page:
This page was last updated on
Sep 26, 2026